Robust In Situ Magnetic Resonance Imaging of Heterogeneous Catalytic Hydrogenation with and without Hyperpolarization

ChemCatChem ◽  
2018 ◽  
Author(s):  
Kirill Viktorovich Kovtunov ◽  
Dmitry Lebedev ◽  
Alexandra Svyatova ◽  
Ekaterina V. Pokochueva ◽  
Igor P. Prosvirin ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Catalytic Hydrogenation ◽  
Resonance Imaging ◽  
Heterogeneous Catalytic ◽  
Heterogeneous Catalytic Hydrogenation

scholarly journals Cover Feature: Robust In Situ Magnetic Resonance Imaging of Heterogeneous Catalytic Hydrogenation with and without Hyperpolarization (ChemCatChem 3/2019)

ChemCatChem ◽  
2019 ◽  
Vol 11 (3) ◽  
pp. 895-895 ◽  
Author(s):  
Kirill V. Kovtunov ◽  
Dmitry Lebedev ◽  
Alexandra Svyatova ◽  
Ekaterina V. Pokochueva ◽  
Igor P. Prosvirin ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Catalytic Hydrogenation ◽  
Resonance Imaging ◽  
Heterogeneous Catalytic ◽  
Heterogeneous Catalytic Hydrogenation

Switchable 19F MRI polymer theranostics: towards in situ quantifiable drug release

2017 ◽  
Vol 8 (34) ◽  
pp. 5157-5166 ◽  
Author(s):  
A. V. Fuchs ◽  
A. P. Bapat ◽  
G. J. Cowin ◽  
K. J. Thurecht
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Hyperbranched Polymer ◽  
Relaxation Times ◽  
Mri Contrast Agent ◽  
Resonance Imaging ◽  
Mri Contrast ◽  
19F Mri ◽  
Magnetic Resonance Imaging Mri

A switchable polymeric 19F magnetic resonance imaging (MRI) contrast agent was synthesised whereby the transverse (T2) relaxation times increased as a therapeutic was released from a hyperbranched polymer (HBP) scaffold.

Validation of a Magnetic Resonance Imaging Based Method to Study Passive Knee Laxity: An In-situ Study

2021 ◽  
pp. 103733
Author(s):  
Jessica C. Kupper ◽  
Nazanin Sinaei ◽  
Lindsey Westover ◽  
Payam Zandiyeh ◽  
Janet L. Ronsky
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Knee Laxity ◽  
Resonance Imaging ◽  
In Situ Study

scholarly journals The Role of Preoperative Magnetic Resonance Imaging for Detecting the Extent of Disease and Predicting the Prognosis of Ductal Carcinoma In Situ

2009 ◽  
Vol 12 (2) ◽  
pp. 106 ◽  
Author(s):  
Yoo Seung Chung ◽  
Youn Soo Lee ◽  
Su-Kyung Jeh ◽  
Byung-Joo Song ◽  
Jeong Soo Kim ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Resonance Imaging ◽  
Preoperative Magnetic Resonance ◽  
Extent Of Disease

scholarly journals Magnetic resonance imaging based 3-dimensional printed breast surgical guide for breast-conserving surgery in ductal carcinoma in situ: a clinical trial

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Zhen-Yu Wu ◽  
Aisha Alzuhair ◽  
Heejeong Kim ◽  
Jong Won Lee ◽  
Il Yong Chung ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Breast Conserving Surgery ◽  
Resonance Imaging ◽  
Surgical Guide

Abstract Breast-conserving surgery (BCS) is performed in patients with ductal carcinoma in situ (DCIS) because of the small size of the tumor. It is essential to know the quantitative extent of the tumor before performing this precise partial resection surgery. A three-dimensional printed (3DP) breast surgical guide (BSG) was developed using information obtained from supine magnetic resonance imaging (MRI) and 3D printing technology and it was used for treating patients with breast cancer. Here, we report our experience with the application of the BSG for patients with DCIS. Patients with breast cancer who underwent BCS from July 2017 to February 2019 were included in this study. The patients underwent partial resection with a supine-MRI based 3DP-BSG. A total of 102 BCS using 3DP-BSG were conducted, and 11 cases were DCIS. The patients’ median age was 56 years (range, 38–69 years). The mean tumor diameter was 1.3 ± 0.9 cm. The median surgical time was 70 min (range, 40–88 min). All patients had tumor-free resection margins. The median distance from the tumor to the margin was 11 mm (range, 2–35 mm). Direct demarcation of the tumor extent in the breast and a pain-free procedure are the advantages of using 3DP-BSG in patients with DCIS. Trial registration: Clinical Research Information Service (CRIS) Identifier Number: KCT0002375, KCT0003043.

Sign in / Sign up

Export Citation Format

Share Document